Hypromellose Acetate Succinate: Your Key to Advanced Pharmaceutical Formulations
Unlock enhanced drug delivery with our high-quality Hypromellose Acetate Succinate for superior enteric coating and solid dispersions.
Get a Quote & SampleProduct Core Value
Hypromellose Acetate Succinate
This product is a white or light yellow powder or granule, odorless and tasteless. It is primarily utilized as an enteric coating material, offering excellent film-forming properties without the need for plasticizers. Its solubility in the upper small intestine ensures efficient drug absorption. Additionally, it serves as a polymer carrier for solid dispersions, significantly enhancing the solubility of poorly soluble active pharmaceutical ingredients (APIs). It is versatile enough for both aqueous and organic coating systems, supporting advanced drug delivery solutions.
- Discover the benefits of using Hypromellose Acetate Succinate for solid dispersion technology to improve bioavailability of challenging APIs.
- Achieve precise drug release profiles with hypromellose acetate succinate enteric coating for targeted delivery.
- Explore the versatility of HPMCAS for aqueous coating applications, offering a more sustainable processing option.
- Enhance your formulations with this essential pharmaceutical excipient hypromellose acetate succinate, meeting USP/CP standards.
Key Advantages Offered
Enhanced Solubility
Leverage HPMCAS for drug solubility enhancement, crucial for poorly soluble compounds, leading to improved therapeutic outcomes.
Controlled Drug Release
Implement precise controlled release formulations with HPMCAS, ensuring drugs are released at the desired location and rate within the digestive tract.
Versatile Coating Capabilities
Benefit from its suitability for both aqueous and organic systems, simplifying your coating processes and reducing environmental impact when using HPMCAS for aqueous coating.
Key Applications
Enteric Coating
As a leading enteric coating material, HPMCAS protects sensitive drugs from gastric acid and targets release in the small intestine, supporting effective hypromellose acetate succinate enteric coating strategies.
Solid Dispersion
The product is a leading polymer for amorphous solid dispersions, vital for improving the absorption of poorly soluble drugs, a key area for hypromellose acetate succinate solid dispersion applications.
Taste Masking
Its odorless and tasteless nature, combined with its film-forming abilities, makes it suitable for taste masking, contributing to better patient compliance.
Controlled Release Matrix Systems
When used in matrix systems, HPMCAS provides a reliable method for developing sustained or delayed drug release profiles, aligning with controlled release formulations objectives.